# Chronic Hepatitis C Virus Infection:  Developing Direct-Acting Antiviral Drugs for Treatment Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/chronic-hepatitis-c-virus-infection-developing-direct-acting-antiviral-drugs-for-treatment-guidance-for-industry/930fbcbb-8430-4e5f-ad06-452dba6d03ff

> FDA guidance document: Chronic Hepatitis C Virus Infection:  Developing Direct-Acting Antiviral Drugs for Treatment Guidance for Industry. Issue date: November 07, 2017. Get complete insights and analysis.

---

## Details

- Title: Chronic Hepatitis C Virus Infection:  Developing Direct-Acting Antiviral Drugs for Treatment Guidance for Industry
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2017-11-07
- Last Changed: 2020-05-04
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2013-D-1170">FDA-2013-D-1170</a>

## Related Documents

- [Smallpox (Variola Virus) Infection: Developing Drugs for Treatment or Prevention Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/smallpox-variola-virus-infection-developing-drugs-for-treatment-or-prevention-guidance-for-industry/c6eb4d8b-888a-4dc5-bb4d-877f66f968fb)
- [Recurrent Herpes Labialis:  Developing Drugs for Treatment and Prevention](https://www.globalkeysolutions.net/guidances/guidance-document/recurrent-herpes-labialis-developing-drugs-for-treatment-and-prevention/e4e0fd38-d19b-43b7-9f6b-13b91c093857)
- [Vulvovaginal Candidiasis:  Developing Drugs for Treatment](https://www.globalkeysolutions.net/guidances/guidance-document/vulvovaginal-candidiasis-developing-drugs-for-treatment/3c14a50c-15d0-4ad3-94ec-76a32afa2bdb)